Sema Investment is a venture capital firm based in Seoul, South Korea. Founded in 2015 and established by the Korea Science and Technology Institute, it specializes in investments in public technology companies.
Break & Company specializes in trading card grading services. It operates a platform offering professional grading, customized protective slabs, and transparent evaluation processes to enhance card value, authenticity assurance, and preservation for various types of collectible cards.
Recl
Series A in 2024
Recl operates a platform that collects and recycles used clothing, enabling a circular economy by refurbishing items and selling them through a used clothing e-commerce channel, including bulk sales, to promote sustainable fashion.
Veluga
Series A in 2023
Veluga is a membership service that delivers curated craft beer selections twice a month, accompanied by complementary snack pairings.
KB-Element
Venture Round in 2023
KB-Element is a graphene development and production company that also produces intermediate graphene items and novel materials, and it develops graphene and CNT coating materials for semiconductor and display applications, including anti-static agents, large-area coating equipment, conductive pastes, thermally conductive and interface materials, electromagnetic shielding materials, and other functional materials to address electromagnetic interference.
EGNIS
Series B in 2023
EGNIS is a supplier of food products.
Zero X And
Seed Round in 2023
Zero X And is a developer specializing in blockchain games and services, aimed at creating a decentralized metaverse. The company provides a framework and building blocks for NFT gaming, facilitating the management and exchange of non-fungible tokens within blockchain projects. By offering innovative solutions, Zero X And enables game developers to enhance user engagement and explore new monetization strategies for digital assets. Its focus on integrating blockchain technology with gaming positions it as a significant player in the evolving landscape of digital entertainment.
One Curegen
Series A in 2021
One Curegen develops diagnostic anti-cancer drugs.
Gloud
Gloud offers dental digital and digital practice transformation services.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.